Olaratumab for the treatment of soft-tissue sarcoma.

about

Olaratumab for the treatment of soft-tissue sarcoma.

Item

http://www.wikidata.org/entity/Q38651664

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Olaratumab for the treatment of soft-tissue sarcoma.

@en

type

Item

label

Olaratumab for the treatment of soft-tissue sarcoma.

@en

prefLabel

Olaratumab for the treatment of soft-tissue sarcoma.

@en

P1476

Olaratumab for the treatment of soft-tissue sarcoma

@en

P2093

Alexandra Pender

http://www.w3.org/2001/XMLSchema#string

Robin L Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity

PDGFR-alpha as a potential therapeutic target in uterine sarcomas.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Amplification of chromosomal segment 4q12 in non-small cell lung cancer

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Olaratumab: First Global Approval.

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

P304

2151-2157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2017-0210

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexandra Pender

Robin L Jones

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28745071

http://www.w3.org/2001/XMLSchema#string

Olaratumab for the treatment of soft-tissue sarcoma.

about

Olaratumab for the treatment of soft-tissue sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698